Webinars

02.09.21

National Roadmap on State-Level Efforts to End the Nation’s Drug Overdose Epidemic

The American Medical Association (AMA) and Manatt Health partnered to create the “National Roadmap on State-Level Efforts to End the Nation’s Drug Overdose Epidemic”—a new policy roadmap for 2021.




01.11.21

Unpacking the Anti-Kickback and Stark Reforms

On November 20, 2020, the Department of Health and Human Services (HHS) published two rules that finalize sweeping reforms to the regulations governing fraud and abuse in the Medicare and Medicaid programs.




12.15.20

Healthcare M&A in the Age of COVID-19—and Beyond

After years of growth, healthcare deal activity slowed in the first half of 2020, with deal volume slipping below 500 for the first time since 2015.




12.07.20

Medicaid Managed Care Payment Policies to Support Pediatric Providers

  By Cindy Mann, Partner, Manatt Health | Sandy L. Chung, MD, FAAP, FACHE, CEO, Trusted Doctors, Immediate Past President, Virginia Chapter AAP | Andy Schneider, Research Professor of the Practice, Georgetown University Center for Children and Families What Actions Can ...




11.17.20

Post-Election: How Will the 2020 Election Results Impact Healthcare?

Healthcare continues to be one of the key factors driving voters’ decisions in the upcoming elections.




11.13.20

Mitigating Coverage Loss When Medicaid Continuous Coverage Requirements Expire

As a condition of receiving enhanced federal funding under the Families First Coronavirus Response Act (FFCRA), states are required to maintain continuous coverage for Medicaid enrollees during the COVID-19 public health emergency (PHE).




10.28.20

Pre-Election: How Will the 2020 Election Results Impact Healthcare?

Healthcare continues to be one of the key factors driving voters’ decisions in the upcoming elections.




10.13.20

Navigating the Surge in Telehealth Transactions

The first quarter of 2020 saw venture capital funding for telemedicine companies surging to $788 million—a jump of 258% over last year.




10.08.20

Navigating FDA Regulation During COVID-19

Using the Emergency Use Authorization (EUA) process, the Food and Drug Administration (FDA) has made enormous strides since the start of the COVID-19 crisis to facilitate the availability of diagnostic tests, ventilators, personal protective equipment and other critical medical technologies.




10.06.20

Implementing the ONC Information Blocking Rule

In March, the federal Office of the National Coordinator for Health Information Technology (ONC) issued a final rule implementing the information blocking prohibition in the 21st Century Cures Act.